%0 Journal Article
%T Acute Thoracic Syndrome in Children: Epidemiological, Diagnostic and Evolutionary Aspects at the Albert Royer National ChildrenĄ¯s Hospital in Dakar Senegal
%A Guillaye Diagne
%A Papa Souleye Sow
%A Khadim Bop
%A Maimouna Sow
%A Idrissa Demba Ba
%J Open Journal of Pediatrics
%P 763-773
%@ 2160-8776
%D 2023
%I Scientific Research Publishing
%R 10.4236/ojped.2023.136084
%X Acute chest syndrome (ACS) is a serious pulmonary complication of sickle
cell disease. It is estimated to be responsible for a quarter of deaths in the
pediatric sickle cell population. In Senegal, there are not enough pediatric
stu</span><span style=\"font-family:Verdana;\">dies in this area. The objective of our
study was to determine the epidemio</span><span style=\"font-family:Verdana;\">logical, diagnostic and evolutionary
characteristics of ATS at the Albert Royer National ChildrenĄ¯s Hospital
(CHNEAR) in Dakar. This was a retrospective study in patients hospitalized at
CHNEAR for ATS from January 1, 2021 to March 31, 2022. We included patients
hospitalized and diagnosed with ATS. We had collected 102 patients, </span><i><span style=\"font-family:Verdana;\">i.e.</span></i><span style=\"font-family:Verdana;\"> a hospital incidence of 2.96%. The
average age of the children was 9 years old; the sex ratio was 1.04. The </span><span style=\"font-family:Verdana;\">main symptoms on admission were hypoxemia
(97.06%), chest pain</span><span style=\"font-family:Verdana;\"> (77.45%), dyspnea (77.45%) and fever (65.69%).
52.94% of patients had an associated vaso-occlusive crisis (VOC). The chest
x-ray was abnormal in 92 patients, a rate of 90.20% and showed images of
pneumonia (71%); bronchitis (17.65%) and pleurisy (0.98%). None of the children
benefited from a pulmonary ultra</span><span style=\"font-family:Verdana;\">sound. The
treatment associated </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">with </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">analgesics (100%),
broad-spectrum antibiotics</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"> (100%), oxygen therapy (100%), hydration (95.09%),
transfusion (73.53%), non-ventilation invasive (6.86%), intubation (2.94%) and
beta</span></span></span><span><span><span style=\"font-family:&quot;\"> </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">2</span></span></span><span><span><span style=\"font-family:&quot;\"> </span></span></span><span><span><span style=\"font-family:&quot;\"><span style=\"font-family:Verdana;\">mimetics (12.75%). No patient benefited from incentive spirometry. Almost </span><span style=\"font-family:Verdana;\">all of the patients 95.10% (n = 97) had a
favorable
%K Acute Chest Syndrome
%K Sickle Cell Disease
%K Children
%K Senegal
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=128194